O-054 Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3-year results with the application of a specific flow-diverter occlusion classification

ConclusionsA high rate of aneurysm occlusion, low morbidity, and absence of aneurysm rupture emphasize the PED as a safe treatment strategy for small and medium-sized aneurysms located along the ICA and VA in the long term.Disclosures R. Hanel: 1; C; Unrestricted research grant from NIH, Interline Endowment, Microvention, Stryker, CNX. 2; C; Medtronic, Stryker, Cerenovous, Microvention, Balt, Phenox, Rapid Medical, and Q’Apel. He is on advisory board for MiVI, eLum, Three Rivers, Shape Medical and Corindus. 4; C; InNeuroCo, Cerebrotech, eLum, Endostream, Three Rivers Medical Inc, Scientia, RisT, BlinkTBI, and Corindus. G. Cortez: None. D. Lopes: 2; C; Asahi, Medtronic, and Stryker; honoraria from Siemens, Medtronic, Stryker, and Phenox. P. Nelson: 2; C; Medtronic, Phenox, and GmbH. A. Siddiqui: 2; C; Amnis Therapeutics, Boston Scientific, Canon Medical Systems USA, Cerebrotech Medical Systems, Claret Medical, Corindus, Endostream Medical, Guidepoint Global Consulting, Imperative Care, Integra, Rap. 4; C; in Amnis Therapeutics, Apama Medical, BlinkTBI, Buffalo Technology Partners, Cardinal Health, Cerebrotech Medical Systems, Claret Medical, Cognition Medical, Endostream Medical Ltd, Imperative Care, I. P. Jabbour: 2; C; Medtronic, Cerenovus, and Microvention. V. Pereira: 1; C; Philips. 2; C; Stryker, Penumbra, Balt, Medtronic, and Neurovasc. I. István: 2; C; Medtronic. O. Zaidat: 2; C; Medtronic, Stryker, Penumbra, and Cerenovus. C. Bettegowda: 2; C; Depuy-Synthe...
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: SNIS 19th annual meeting oral abstracts Source Type: research